StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4113.T$714.00-3.77%
Fair $714.00+0.0%

4113.T

Taoka Chemical Company, Limited

Basic Materials / Specialty ChemicalsTokyo

$714.00

-28.00 (-3.77%)

Fairly Valued+0.0%Fair Value $714.00Fund rank 27/100 · Data gapFallback financials|
SA 54/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $2.5B · quality 46.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

54/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 4113.TLocal privado en este navegador · Taoka Chemical Company, Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$10.2B

P/E

6.7x

↓

EV/EBITDA

3.0x

↓

ROE

8.0%

↑

Gross Margin

18.3%

↓

Debt/Equity

0.08

↓
52-Week Range$714
$714$1547

TradingView lightweight chart

4113.T price, volumen y niveles de valoración

Último $714.00Periodo +160.6%
Fair value: $714.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-2.6%

FCF CAGR

—

FCF margin

9.9%

FCF / Net income

2.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $29.93B · net income $1.48B · FCF $2.96B

2022-FY → 2025-FY

Gross margin

18.3%-1.2% pts

Operating margin

6.3%-2.1% pts

Net margin

4.9%-1.4% pts

FCF margin

9.9%+20.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$29.93B$29.93B$28.54B$30.17B$32.37B
Net Income$1.48B$1.48B$820.0M$310.6M$2.06B
EBITDA$3.46B$3.46B$2.60B$1.95B$4.25B
EPS103.18103.1857.2621.68144.03
Gross Margin18.3%18.3%16.0%13.3%19.5%
Operating Margin6.3%6.3%3.8%1.5%8.4%
Net Margin4.9%4.9%2.9%1.0%6.4%
Balance Sheet
Debt/Equity0.080.080.130.260.05
Current Ratio2.012.01———
Cash Flow
Free Cash Flow$2.96B$2.96B$2.49B$-2.85B$-3.41B
Returns
ROE8.0%8.0%4.8%1.9%12.3%
Valuation
P/E6.676.6713.8135.387.29
EV/EBITDA3.053.054.837.423.56
P/B0.550.550.660.660.90
Growth & Yield
Revenue Growth4.9%4.9%-5.4%-6.8%—
EPS Growth80.2%80.2%164.1%-84.9%—
Dividend Yield0.8%0.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-15.0%

fácil

EPS terminal req.

$63.36

Spread vs growth

95.2%

5Y implied EPS CAGR

-5.8%

fácil

EPS terminal req.

$76.66

Spread vs growth

86.0%

10Y implied EPS CAGR

1.8%

fácil

EPS terminal req.

$123.46

Spread vs growth

78.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.4%

Total return

-38.4%

Start / end P/E

20.5x → 6.9x

EPS bridge

57.26 → 103.18

Residual

-53.2%

EPS growth+80.2%
Multiple rerating-66.3%
Dividend+0.8%
Residual / FX / buybacks / cross-term-53.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.